ClinicalTrials.Veeva

Menu

Efficacy on Anxiety of the Digital Music Application Versus Equimolar Mixture of Oxygen and Nitrous Oxide in Patients Receiving CT-guided Lumbar Infiltration (MKI-TDM)

C

Centre Hospitalier Universitaire de Nīmes

Status

Not yet enrolling

Conditions

Anxiety
Low Back Pain

Treatments

Other: Music Care® device
Other: EMONO

Study type

Interventional

Funder types

Other

Identifiers

NCT06928740
NIMAO/2024-2/FT01

Details and patient eligibility

About

Since the Covid-19 crisis, patients appear more stressed, with increasing fear of exams and the hospital environment, in particular for CT scan teams, which require injections. Currently, an equimolar mixture of oxygen and nitrous oxide (EMONO) is used to calm patients. However, the patient's prone position complicates its use, with patients sometimes in painful position and the discomfort of gas inhalation (nausea, dizziness, etc.), as well as reduced lung capacity. Greater patient anxiety increases the risk of complications, or even failure, (unexpected movement, stiffness, refusal to complete the procedure, etc.). In this study, music therapy using Music Care® tablets, was tested to replace EMONO. The study authors hypothesize that the use of the Music Care® device will have a comparable efficacy to that of EMONO (non-inferiority) in reducing patient anxiety during CT-guided lumbar infiltration. Furthermore, the study authors hypothesize that this simple, non-invasive method, with no contraindications for the patient, will be better tolerated and appreciated by both the patient and the paramedical team in charge of the treatment.

Enrollment

128 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patient must have given their free and informed consent and signed the consent form
  • The patient must be a member or beneficiary of a health insurance plan
  • Patient with low back pain and an indication for CT-guided foraminal, posterior joint, or pudendal injection
  • Patient with an anxiety score ≥ 35/100 based on the STAI-ETAT questionnaire

Exclusion criteria

  • The subject is participating in another drug or category I interventional study, or is in a period of exclusion determined by a previous study
  • The subject refuses to sign the consent
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • Patient who has already received a CT-guided posterior articular, foraminal, epidural, or pudendal injection
  • Indication for epidural or cervical injection
  • Patient who is deaf or hard of hearing
  • Contraindications to EMONO
  • Facial or head trauma making it impossible to wear a nasofacial mask or headphones
  • Patient who has taken an anxiolytic medication within 24 hours prior to the injection

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

128 participants in 2 patient groups

Music Care
Experimental group
Treatment:
Other: Music Care® device
Control
Active Comparator group
Treatment:
Other: EMONO

Trial contacts and locations

1

Loading...

Central trial contact

Florelle TERRA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems